Key result
Bendroflumethiazide interruption in Gordon syndrome triggers hyperkalemia and self-terminating polymorphic ventricular arrhythmias.
Why the study?
The clinical implications of life-threatening polymorphic ventricular arrhythmia with torsade-like morphology in Gordon's syndrome with hyperkalaemia are unclear, especially when original rhythm recordings are unavailable.
Case Report (n=1)
No
This case highlights the importance of uninterrupted thiazide therapy in Gordon's syndrome to prevent severe hyperkalaemia and potential life-threatening arrhythmias, though the exact mechanism of the reported torsade de pointes remains unverified.
Answers are grounded in this paper and cite their sources.
Thiazide interruption may risk hyperkalaemia-related arrhythmia in Gordon syndrome; this case leaves open prospective surveillance studies.
Gordon's syndrome (pseudohypoaldosteronism type II) is a rare, inherited tubulopathy characterised by saltsensitive hypertension, hyperkalaemia, and metabolic acidosis despite preserved renal function.Pathogenic variants affecting the with-no-lysine (K) signalling pathway include WNK1, WNK4, KLHL3, and CUL3.We report the case of a 37-year-old woman with genetically confirmed CUL3-related Gordon's syndrome who developed hyperkalaemia after a three-week interruption of bendroflumethiazide.During pre-hospital assessment, ambulance clinicians documented a self-terminating rhythm that they identified as torsade de pointes.The original recording cannot be retrieved; consequently, the rhythm classification, preceding QT interval, and possible alternative rhythm or artefact could not be independently assessed.Point-of-care venous blood gas potassium was 4.8 mmol/L, whereas formal laboratory potassium was 6.1 mmol/L.The sampling and processing information available did not establish the cause of this discrepancy.Subsequent echocardiography, computed tomography coronary angiography, cardiac magnetic resonance imaging, ambulatory monitoring, exercise testing, and additional electrical assessment did not identify a definitive alternative substrate, although an intermittent electrical disorder could not be excluded.Following treatment of hyperkalaemia and multidisciplinary cardiology and electrophysiology review, an extravascular implantable cardioverter-defibrillator was implanted.Bendroflumethiazide was resumed, with subsequent improvement in potassium control.This case highlights the importance of uninterrupted thiazide therapy in Gordon's syndrome, assessment of discordant potassium measurements, and careful interpretation of a reported serious rhythm event when its original tracing is unavailable.The temporal association with hyperkalaemia does not establish that it caused torsade de pointes.
No takes yet. Share an insight, caveat, or question.
Kayani et al. (2026) conducted a case report in Gordon's syndrome and hyperkalaemia (n=1). Bendroflumethiazide interruption was evaluated on Development of polymorphic ventricular arrhythmia. A 37-year-old woman with Gordon's syndrome developed hyperkalaemia and a reported self-terminating torsade de pointes-like arrhythmia following a three-week interruption of bendroflumethiazide.
Synapse has enriched 10 related papers. Consider them for comparative context: